The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Author [ Title(Asc)] Type Year
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Kountouras, J., Polyzos S. A., Doulberis M., Stergiopoulos C., & Katsinelos P. (2018).  Comment on "Therapeutic Application of an Extract of Ameliorates the Development of Allergic Airway Disease".. J Immunol. 200(9), 3027.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2012).  Comment on: Jeon et al. Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012;35:520-525.. Diabetes Care. 35(7), e53; author reply e54.
Kazakos, E. I., Dorrell N., Polyzos S. A., Deretzi G., & Kountouras J. (2017).  Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics".. World J Gastroenterol. 23(33), 6194-6196.
Makri, E. S., Makri E., & Polyzos S. A. (2022).  Combination Therapies for Nonalcoholic Fatty Liver Disease.. J Pers Med. 12(7), 
Anastasilakis, A. D., Polyzos S. A., Yavropoulou M. P., & Makras P. (2020).  Combination and sequential treatment in women with postmenopausal osteoporosis.. Expert Opin Pharmacother. 21(4), 477-490.
Nikolaidis, N., Polyzos S. A., Giouleme O., Katsinelos P., Eugenidis N., Zeglinas C., et al. (2016).  Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation.. Med Hypotheses. 95, 34.
Polyzos, S. A., & Goulis D. G. (2011).  Coincidental thyroid papillary microcarcinoma in a patient treated for a toxic adenoma of the thyroid.. Arch Iran Med. 14(2), 149-51.
Anastasilakis, A. D., Ruggeri R-M., Polyzos S. A., Makras P., Molyva D., Campennì A., et al. (2013).  Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.. Metabolism. 62(10), 1350-6.
Polyzos, S. A., & Terpos E. (2016).  Clinical vertebral fractures following denosumab discontinuation.. Endocrine. 54(1), 271-272.
Anastasilakis, A. D., Polyzos S. A., Makras P., Aubry-Rozier B., Kaouri S., & Lamy O. (2017).  Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases.. J Bone Miner Res. 32(6), 1291-1296.
Polyzos, S. A., & Anastasilakis A. D. (2009).  Clinical complications following thyroid fine-needle biopsy: a systematic review.. Clin Endocrinol (Oxf). 71(2), 157-65.
Potoupni, V., Georgiadou M., Chatzigriva E., Polychronidou G., Markou E., Gakis C. Zapantis, et al. (2021).  Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.. J Gastroenterol Hepatol.
Anastasilakis, A. D., Polyzos S. A., Makras P., Gkiomisi A., Sakellariou G., Savvidis M., et al. (2015).  Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.. Expert Opin Ther Targets. 19(3), 299-306.
Anastasilakis, A. D., Polyzos S. A., Yavropoulou M. P., Ntenti C., Mandanas S., & Makras P. (2021).  Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion.. Endocrine.
Polyzos, S. A., Anastasilakis A. D., Kountouras J., Makras P., Papatheodorou A., Kokkoris P., et al. (2016).  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.. J Bone Miner Metab. 34(4), 447-56.
Sakellariou, G. T., Anastasilakis A. D., Bisbinas I., Oikonomou D., Gerou S., Polyzos S. A., et al. (2015).  Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.. Rheumatology (Oxford). 54(5), 908-14.
Anastasilakis, A. D., Polyzos S. A., Makras P., Rauner M., Sonnleitner L., Hawa G., et al. (2019).  Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.. J Musculoskelet Neuronal Interact. 19(3), 253-257.
Makri, E. S., Evripidou K., & Polyzos S. A. (2024).  Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.. J Gastroenterol Hepatol.
Polyzos, S. A., Aronis K. N., Kountouras J., Raptis D. D., Vasiloglou M. F., & Mantzoros C. S. (2016).  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.. Diabetologia. 59(1), 30-43.
Anastasilakis, A. D., Koulaxis D., Kefala N., Polyzos S. A., Upadhyay J., Pagkalidou E., et al. (2017).  Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD. Metabolism. 73, 1-8.
Anastasilakis, A. D., Polyzos S. A., Saridakis Z. G., Kynigopoulos G., Skouvaklidou E. C., Molyvas D., et al. (2014).  Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.. J Clin Endocrinol Metab. 99(9), 3247-55.
Polyzos, S. A., Kountouras J., & Tsoukas M. A. (2015).  Circulating homocysteine in nonalcoholic fatty liver disease.. Eur J Intern Med. 26(2), 152-3.
Anastasilakis, A. D., Polyzos S. A., Skouvaklidou E. C., Kynigopoulos G., Saridakis Z. G., Apostolou A., et al. (2016).  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.. Metabolism. 65(10), 1459-65.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Migdalis I., et al. (2014).  Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study.. Biomarkers. 19(8), 660-6.
Makri, E., Orfanidou M., Makri E. S., Goulas A., Terpos E., & Polyzos S. A. (2024).  Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.. J Clin Exp Hepatol. 14(3), 101353.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.